AMH, FSH and AFC Explained: What Your Ovarian Reserve Tests Really Tell You

2026-09-14T08:32:58+00:00September 14th, 2026|Categories: News|Tags: , , , , , , , , , |

If you have undergone a fertility assessment, you have probably encountered three abbreviations: AMH, FSH and AFC. These are among the most commonly used ovarian reserve tests, but they do not all measure the same thing—and they certainly do not provide a simple percentage chance of becoming pregnant. A woman can have low AMH and

IVF with Your Own Eggs After 40: When Is It Possible and What Factors Matter Most?

2026-09-14T08:26:17+00:00September 14th, 2026|Categories: News|Tags: , , , , , , , |

For many women considering IVF in their 40s, one question comes before almost everything else: Can I still try with my own eggs? The answer is highly individual. IVF with your own eggs after 40 can result in pregnancy and live birth, but reproductive potential changes substantially throughout the 40s. A woman at 40 with

Early Menopause and Fertility: Is Ovarian Function Ever Possible to Restore?

2026-09-14T08:20:29+00:00September 14th, 2026|Categories: News|Tags: , , , , , , , |

Being told that your ovarian reserve is very low—or that you may be approaching menopause earlier than expected—can make pregnancy seem impossible. But early menopause and fertility are more complex than a simple “fertile or infertile” diagnosis. Ovarian function declines along a continuum. Some women experience diminished ovarian reserve while still menstruating regularly. Others enter

Stem Cell Therapy for Female Fertility, Ovarian Aging & Menopause

2026-09-14T08:15:17+00:00September 14th, 2026|Categories: News|Tags: , , , , , , , |

Female fertility does not decline suddenly at menopause. It changes progressively as the ovaries age, often beginning years before menstrual cycles stop. During this transition, women may experience reduced ovarian reserve, poorer response to IVF stimulation, irregular cycles and eventually perimenopause, followed by menopause and postmenopause. For women who still wish to conceive—particularly those experiencing

Exosome Therapy for Female Fertility: How Regenerative Cell Signaling May Support Ovarian and Endometrial Health

2026-09-14T08:05:11+00:00September 14th, 2026|Categories: News|Tags: , , , , , , , |

Exosome therapy for female fertility represents one of the most rapidly developing areas of regenerative reproductive medicine. Unlike conventional fertility treatments that primarily act through hormones, medications or laboratory-assisted reproduction, exosome-based approaches focus on something more fundamental: communication between cells. Every tissue in the reproductive system depends on continuous molecular communication. Ovarian cells communicate with

Uterine Rejuvenation with PRP: Endometrial Regeneration & IVF

2026-09-14T07:50:54+00:00September 14th, 2026|Categories: News|Tags: , , , , , , , |

Uterine rejuvenation with PRP is an increasingly important area of regenerative reproductive medicine, particularly for women experiencing persistent thin endometrium, difficult endometrial development or repeated implantation failure. Successful IVF depends on more than producing a good embryo. For pregnancy to begin, the embryo must interact successfully with a receptive and biologically active endometrium—the specialized tissue

Thin Endometrium and IVF: How to Improve Endometrial Thickness

2026-09-14T08:01:46+00:00September 14th, 2026|Categories: News|Tags: , , , , , , , |

Thin endometrium and IVF can be a frustrating combination for patients preparing for embryo transfer. The embryos may be developing well, ovarian stimulation may have been successful and everything may appear ready for transfer—except that the endometrial lining remains thinner than expected. This often leads to an important question: “Can my endometrium be improved before

Recurrent Implantation Failure: Why Good Embryos Sometimes Don’t Implant

2026-09-14T07:39:31+00:00September 14th, 2026|Categories: News|Tags: , , , , , , , |

Recurrent implantation failure can be one of the most frustrating experiences during IVF treatment. Everything may appear to be going well. Good-quality embryos have developed. The endometrium appears suitable. Embryo transfer is uncomplicated. Yet pregnancy does not occur. After repeated unsuccessful embryo transfers, many patients understandably ask: “If the embryos are good, why don't

PRP vs Exosomes vs Stem Cells for Ovarian Rejuvenation: What is the difference?

2026-09-10T11:38:54+00:00September 10th, 2026|Categories: News|Tags: , , , , , , , , , , , |

Regenerative medicine is attracting increasing attention in fertility care, particularly among women with diminished ovarian reserve, low AMH, poor ovarian response or age-related decline in ovarian function. Three approaches frequently discussed are Platelet-Rich Plasma (PRP), exosome therapy and stem cell therapy. Although all three are associated with regenerative medicine, they are not the same treatment.

Diminished Ovarian Reserve: Causes, Symptoms, AMH Levels and Fertility Options

2026-09-10T10:58:15+00:00September 10th, 2026|Categories: News|Tags: , , , , , , , , , , , , , |

Being told that you have diminished ovarian reserve (DOR) can raise many questions. Does it mean that you are running out of eggs? Can you still become pregnant naturally? Does low ovarian reserve mean poor egg quality? Can IVF work with diminished ovarian reserve? And is there anything you can do to improve your fertility?

    Your Name (required)

    Your Email (required)

    Phone

    Country

    Your Message

    Go to Top